50.81USD-1.38%Mkt Cap: 7.98B USDP/E: 72.81Last update: 2026-06-01
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company o…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap7.98B USD
Enterprise Value8.17B USD
Revenue (TTM)1.21B USD
Gross Profit790.27M USD
Net Income (TTM)73.40M USD
Revenue/Share7.769 USD
Last Price50.81 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees3.1K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS09073M1045
Valuation
P/E (Trailing)72.81
P/E (Forward)25.06
PEG0.70
EV/EBITDA22.31
EV/Revenue6.75
P/S6.68
P/B4.01
EPS (TTM)0.70
EPS (Forward)2.06
52W Range
43.2026% of range72.16
52W High72.16 USD
52W Low43.20 USD
Profitability
Gross Margin64.80%
Oper. Margin25.19%
EBITDA Margin30.23%
Profit Margin6.02%
ROE3.83%
ROA2.87%
Growth
Revenue Growth-1.50%
Earnings Growth128.60%
Cash Flow & Leverage
Operating CF287.56M USD
CapEx (TTM)31.01M USD
FCF Margin24.76%
FCF Yield3.76%
Net Debt76.21M USD
Net Debt/EBITDA0.21
Balance Sheet
Debt/Equity0.23
Current Ratio4.49
Quick Ratio2.80
Book Value/Sh12.90 USD
Cash/Share1.368 USD
Dividends
Fwd Div Rate0.3200 USD
Trail. Div Rate0.3200 USD
Div. Yield0.63%
5Y Avg Yield0.43%
Payout Ratio45.71%
Ex-Div DateMay 18, 2026
Pay DateMay 29, 2026
Splits
Last Split4:1
Split DateNov 30, 2022
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)61.42 USD
Target Range49.00 USD – 75.00 USD
# Analysts12
Ownership
Shares Out.156.57M
Float154.66M
Insiders0.30%
Institutions117.81%
Short Interest
Short Ratio4.9d
Short % Float10.60%
Short % Out.9.30%
Shares Short14.55M
Short (prev mo.)14.00M
Technical
SMA 5052.25 (-2.8%)
SMA 20057.58 (-11.8%)
Beta1.41
S&P 52W Chg27.70%
Avg Vol (30d)2.82M
Avg Vol (10d)3.09M
Technical Indicators
RSI (14)54.4
MACD-1.1272
MACD Signal-1.8714
MACD Hist.+0.7442
BB Upper55.94 USD
BB Middle48.56 USD
BB Lower41.17 USD
BB Width30.42%
ATR (14)2.567 USD
Vol Ratio (20d)0.37x